Table 1.
Demographic and clinical characteristics of the CAPTURE study sample in Japan stratified by CVD status
| Characteristica | Overall (n = 800) | By CVD status | ||
|---|---|---|---|---|
| No CVD (n = 502) | CVD (n = 298) | ASCVDb (n = 268) | ||
| Male, n (%) | 537 (67.1) | 334 (66.5) | 203 (68.1) | 185 (69.0) |
| Female, n (%) | 263 (32.9) | 168 (33.5) | 95 (31.9) | 83 (31.0) |
| Age, years | 65.6 (11.2) | 63.0 (11.0) | 70.0 (10.1) | 70.2 (9.9) |
| Diabetes duration, years | 13.5 (9.0) | 12.1 (7.9) | 16.0 (10.2) | 16.3 (10.3) |
| HbA1c, % | 7.2 (0.9) | 7.2 (1.0) | 7.2 (0.9) | 7.3 (0.9) |
| FPG, mg/dL | 141.8 (39.5) | 141.0 (38.2) | 143.7 (42.6) | 144.1 (41.8) |
| Body weight, kg | 67.8 (13.8) | 68.7 (14.0) | 66.3 (13.2) | 65.7 (12.4) |
| BMI, kg/m2 | 25.6 (4.2) | 25.8 (4.4) | 25.2 (4.0) | 25.0 (3.7) |
| Systolic blood pressure, mmHg | 132.4 (14.7) | 132.5 (14.6) | 132.4 (14.9) | 132.7 (15.0) |
| Diastolic blood pressure, mmHg | 75.8 (10.5) | 77.4 (10.1) | 73.2 (10.7) | 73.2 (10.7) |
| Total cholesterol, mg/dL | 186.9 (37.0) | 193.5 (35.8) | 173.9 (35.9) | 174.7 (36.7) |
| LDL cholesterol, mg/dL | 104.3 (31.1) | 109.8 (31.2) | 94.7 (28.6) | 93.9 (28.7) |
| HDL cholesterol, mg/dL | 56.6 (15.7) | 57.9 (15.9) | 54.3 (15.0) | 55.0 (15.2) |
| Triglycerides, mg/dL | 149.3 (89.4) | 150.0 (92.4) | 148.1 (83.9) | 147.2 (84.0) |
Data are mean (standard deviation) unless otherwise indicated
aNumber of observations differs for each characteristic. bASCVD is a subgroup of CVD
ASCVD atherosclerotic cardiovascular disease, BMI body mass index, CVD cardiovascular disease, FPG fasting plasma glucose, HbA1c glycated hemoglobin, HDL high-density lipoprotein, LDL low-density lipoprotein